OLVIG
CLOV icon

Oliver Lagore Vanvalin Investment Group’s Clover Health Investments CLOV Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 649
2022
Q2 		$0 Hold
20
– – ﹤0.01% 627
2022
Q1 		$0 Buy
+20
New +$58 ﹤0.01% 569

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's CLOV Position: Q3 2022 in Review

Oliver Lagore Vanvalin Investment Group sold out of Clover Health Investments (CLOV) in Q3 2022, closing a stake of 20 shares.

Oliver Lagore Vanvalin Investment Group first reported a position in CLOV in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 175 funds tracked by Wall St. Rank hold CLOV as of Q3 2022.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Clover Health Investments position as of Q3 2022 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 20 Clover Health Investments shares in Q3 2022.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Clover Health Investments in Q1 2022 and held it in 2 quarters.
  • Oliver Lagore Vanvalin Investment Group's Clover Health Investments position peaked at $0 in Q2 2022.
  • 175 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2022.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2022, filed 15 Nov 2022.